RENOVE Trial Overview 📑 episode artwork

EPISODE · Mar 5, 2025 · 2 MIN

RENOVE Trial Overview 📑

from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC

  The RENOVE trial compared reduced-dose versus full-dose DOACs for extended venous thromboembolism VTE treatment in high-risk patients. While the reduced dose cut major bleeding risk by 39% 🚨, it did not meet non-inferiority criteria for preventing VTE recurrence 🔄.

Episode metadata supplied by the publisher feed · Published Mar 5, 2025

NOW PLAYING

RENOVE Trial Overview 📑

0:00 2:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Dr RR Baliga's "Got Knowledge Doc" Podkast?

This episode is 2 minutes long.

When was this Dr RR Baliga's "Got Knowledge Doc" Podkast episode published?

This episode was published on March 5, 2025.

What is this episode about?

  The RENOVE trial compared reduced-dose versus full-dose DOACs for extended venous thromboembolism VTE treatment in high-risk patients. While the reduced dose cut major bleeding risk by 39% 🚨, it did not meet non-inferiority criteria for...

Can I download this Dr RR Baliga's "Got Knowledge Doc" Podkast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!